Clive Ballard
#82,633
Most Influential Person Now
Researcher
Clive Ballard's AcademicInfluence.com Rankings
Clive Ballardbiology Degrees
Biology
#3851
World Rank
#5836
Historical Rank
Neuroscience
#378
World Rank
#395
Historical Rank
Download Badge
Biology
Clive Ballard's Degrees
- PhD Neuroscience University of Oxford
Why Is Clive Ballard Influential?
(Suggest an Edit or Addition)According to Wikipedia, Clive Ballard is a British, world-leading expert in dementia. He is currently Professor of Age-Related Diseases at the University of Exeter and Interim Deputy Pro-Vice-Chancellor and Dean of the University of Exeter Medical School.
Clive Ballard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science (2020) (3697)
- Dementia prevention, intervention, and care (2017) (3617)
- Diagnosis and management of dementia with Lewy bodies (2005) (3346)
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) (2628)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. (1996) (2280)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (1996) (2138)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Alzheimer's disease (2011) (1460)
- Defeating Alzheimer's disease and other dementias: a priority for European science and society (2016) (1172)
- Putting brain training to the test (2010) (1051)
- Cognitive decline in Parkinson disease (2017) (608)
- Donepezil and memantine for moderate-to-severe Alzheimer's disease. (2012) (575)
- The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial (2009) (542)
- Vascular cognitive impairment (2002) (512)
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial (2014) (506)
- Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial (2006) (498)
- Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial (2011) (478)
- Overlap between pathology of Alzheimer disease and vascular dementia. (1999) (473)
- Atypical antipsychotics for aggression and psychosis in Alzheimer's disease (2006) (463)
- Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies (2000) (451)
- Depression in Parkinson disease—epidemiology, mechanisms and management (2011) (445)
- A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry (2003) (432)
- Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial (2009) (429)
- Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment (2012) (426)
- Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial (2011) (425)
- White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging (1999) (412)
- Incidence and Prediction of Falls in Dementia: A Prospective Study in Older People (2009) (408)
- Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD (2001) (399)
- Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. (2002) (399)
- Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial (2003) (386)
- Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology (2006) (374)
- Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. (2002) (370)
- The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. (2000) (354)
- Management of agitation and aggression associated with Alzheimer disease (2009) (347)
- Management of behavioral problems in Alzheimer's disease (2010) (338)
- Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study (2005) (335)
- Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. (1999) (326)
- Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments (2001) (324)
- Differences in neuropathologic characteristics across the Lewy body dementia spectrum (2006) (308)
- Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. (1999) (304)
- A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia (2001) (302)
- Cholinesterases: roles in the brain during health and disease. (2005) (292)
- Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future (2013) (288)
- Non-pharmacological interventions in dementia (2004) (286)
- Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial (2005) (282)
- Prevalence of Postnatal Psychiatric Morbidity in Mothers and Fathers (1994) (280)
- Neuroleptic drugs in dementia: benefits and harm (2006) (279)
- Donepezil for the treatment of agitation in Alzheimer's disease. (2007) (276)
- Towards defining the neuropathological substrates of vascular dementia (2004) (275)
- Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia (2000) (268)
- MRI volumetric study of dementia with Lewy bodies (2000) (267)
- The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. (2002) (263)
- Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia (1999) (257)
- Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition (2002) (237)
- A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial) (2008) (236)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) (232)
- Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options (2019) (230)
- Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias (2005) (225)
- Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial (2012) (225)
- The psychosis spectrum in Parkinson disease (2017) (224)
- Anxiety, depression and psychosis in vascular dementia: prevalence and associations. (2000) (218)
- Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. (2008) (213)
- Dementia with Lewy bodies. (2007) (212)
- Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms (2017) (211)
- Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia (2001) (211)
- Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry (2002) (207)
- Autonomic dysfunction in dementia (2006) (206)
- Hypertension is a potential risk factor for vascular dementia: systematic review (2011) (206)
- Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. (2013) (204)
- Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. (2000) (204)
- A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. (2013) (201)
- Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study (2021) (201)
- CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study (2010) (201)
- Medial temporal lobe atrophy on MRI in dementia with Lewy bodies (1999) (200)
- Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria (2008) (198)
- Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity? (2004) (197)
- Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. (2005) (197)
- Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease (1998) (193)
- Prospective Follow-Up Study Between 3 and 15 Months After Stroke: Improvements and Decline in Cognitive Function Among Dementia-Free Stroke Survivors >75 Years of Age (2003) (190)
- α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease (1999) (190)
- Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study (2009) (185)
- Is physical activity a potential preventive factor for vascular dementia? A systematic review (2010) (183)
- A comparison of 99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping (2002) (183)
- Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. (2001) (176)
- The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. (2001) (170)
- Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers (2003) (169)
- Improving quality of life for people with dementia in care homes: making psychosocial interventions work. (2012) (167)
- A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. (2001) (164)
- Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication (2000) (163)
- Quality of Life for People With Dementia Living in Residential and Nursing Home Care: The Impact of Performance on Activities of Daily Living, Behavioral and Psychological Symptoms, Language Skills, and Psychotropic Drugs (2001) (161)
- Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology (2009) (160)
- Delusions associated with elevated muscarinic binding in dementia with Lewy bodies (2000) (160)
- Endogenous neurogenesis in the human brain following cerebral infarction. (2007) (156)
- Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology (2012) (154)
- Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias (2014) (154)
- Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers (2005) (152)
- Drug repositioning for Alzheimer's disease (2012) (151)
- Altered neurogenesis in Alzheimer's disease. (2006) (151)
- Aromatherapy in dementia (2004) (149)
- The prognosis of dementia with Lewy bodies (2017) (148)
- Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial (2012) (147)
- The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. (2005) (147)
- Management of Neuropsychiatric Symptoms in People with Dementia (2010) (146)
- A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome. (2004) (146)
- An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers (2008) (145)
- The response of agitated behavior to pain management in persons with dementia. (2014) (145)
- The prevalence, associations and symptoms of depression amongst dementia sufferers. (1996) (145)
- Assessment and treatment of pain in people with dementia (2012) (143)
- Parkinson disease-associated cognitive impairment (2021) (141)
- The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review (2014) (140)
- Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach (2018) (140)
- Dementia care mapping as a research tool for measuring quality of life in care settings: psychometric properties (2002) (139)
- Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations (2017) (139)
- The Effect of an Online Cognitive Training Package in Healthy Older Adults: An Online Randomized Controlled Trial. (2015) (139)
- Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia (2006) (138)
- Effectiveness and acceptability of non‐pharmacological interventions to reduce wandering in dementia: a systematic review (2007) (136)
- Assessment and treatment of pain in people with dementia (2013) (133)
- Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. (2004) (132)
- Determining the minimum clinically important differences for outcomes in the DOMINO trial (2011) (132)
- White Matter Hyperintensities Are Associated With Impairment of Memory, Attention, and Global Cognitive Performance in Older Stroke Patients (2004) (131)
- Neuroleptic sensitivity to risperidone in Lewy body dementia (1995) (130)
- Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial (2018) (128)
- A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. (2006) (128)
- Quality of care in private sector and NHS facilities for people with dementia: cross sectional survey (2001) (125)
- Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia (2004) (124)
- The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease (2001) (123)
- Depression and dementia. (2011) (123)
- Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus (2018) (122)
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses (2015) (122)
- Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial (2012) (120)
- Drug repositioning in Alzheimer's disease. (2015) (118)
- Neuropsychiatric aspects of alzheimer’s disease (1999) (117)
- The disconnect between evidence and practice: a systematic review of person‐centred interventions and training manuals for care home staff working with people with dementia (2014) (117)
- Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia (2016) (117)
- Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions (2009) (116)
- The Prevalence, Assessment and Associations of Falls in Dementia with Lewy Bodies and Alzheimer’s Disease (1999) (114)
- A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease (2011) (111)
- Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program. (2016) (111)
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials (2018) (111)
- Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer’s Disease and Related Dementias and Strategic Implications for Stakeholders (2019) (110)
- Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study (2018) (107)
- Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults. (2019) (107)
- Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality (2011) (107)
- Carers' knowledge of dementia, their coping strategies and morbidity (1997) (107)
- Sensory stimulation in dementia (2002) (106)
- Language impairment in dementia: impact on symptoms and care needs in residential homes (2003) (104)
- Dementia in Down's syndrome (2016) (103)
- A Comparison of Medial and Lateral Temporal Lobe Atrophy in Dementia with Lewy Bodies and Alzheimer’s Disease: Magnetic Resonance Imaging Volumetric Study (2001) (103)
- Neuropsychiatric symptoms in dementia: Importance and treatment considerations (2008) (102)
- Agitation and aggression in people with Alzheimer's disease (2013) (102)
- Neurocardiovascular Instability in Cognitive Impairment and Dementia (2002) (101)
- Profile of Neuropsychological Deficits in Older Stroke Survivors without Dementia (2003) (100)
- Autonomic Function Is Impaired in Elderly Stroke Survivors (2005) (100)
- The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies (1997) (100)
- Guidelines for the management of agitation in dementia (2001) (99)
- Pain treatment of agitation in patients with dementia: a systematic review (2011) (98)
- Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia (2002) (98)
- Rate of progression of cognitive decline in Alzheimer’s disease: effect of butyrylcholinesterase K gene variation (2005) (98)
- Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment (2014) (97)
- Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors (2007) (97)
- Nonpharmacological Treatment of Alzheimer Disease (2011) (96)
- Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. (2000) (94)
- Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study) (2019) (94)
- Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. (2006) (92)
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease (2019) (89)
- Association Between Mild Vascular Cognitive Impairment and Impaired Activities of Daily Living in Older Stroke Survivors Without Dementia (2005) (89)
- Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method (2011) (88)
- Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study (2008) (87)
- Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020 (2020) (87)
- Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes (2000) (86)
- Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. (2008) (86)
- Systematic review of services providing information and/or advice to people with dementia and/or their caregivers (2012) (85)
- Regulation of attention and response to therapy in dementia by butyrylcholinesterase. (2003) (85)
- Impact of Behavioral and Psychological Symptoms of Dementia on Caregivers (2000) (84)
- MRI volumetric correlates of white matter lesions in dementia with lewy bodies and Alzheimer's disease (2000) (84)
- Early and Presenting Symptoms of Dementia with Lewy Bodies (2011) (84)
- Quantification and Characterisation of Fluctuating Cognition in Dementia with Lewy Bodies and Alzheimer’s Disease (2000) (84)
- Association among visual hallucinations, visual acuity, and specific eye pathologies in Alzheimer's disease: treatment implications. (1999) (83)
- Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: A cluster randomized trial (2014) (83)
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders (2020) (82)
- Stroke and cognition (2001) (80)
- High prevalence of neurovascular instability in neurodegenerative dementias (1998) (80)
- The effect of staff training on agitation and use of restraint in nursing home residents with dementia: a single-blind, randomized controlled trial. (2010) (80)
- Clinical neurochemistry: developments in dementia research based on brain bank material (1998) (78)
- Health economic evaluation of treatments for Alzheimer′s disease: impact of new diagnostic criteria (2014) (76)
- Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease. (2000) (75)
- Apolipoprotein E ϵ4 Allele, Temporal Lobe Atrophy, and White Matter Lesions in Late-Life Dementias (1999) (75)
- Treating behavioural and psychological signs in Alzheimer's disease (1999) (74)
- Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity (2009) (74)
- A One-Year Follow-Up Study of Depression in Dementia Sufferers (1996) (74)
- A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025 (2018) (74)
- Can psychiatric liaison reduce neuroleptic use and reduce health service utilization for dementia patients residing in care facilities (2002) (73)
- Neurocardiovascular Instability, Hypotensive Episodes, and MRI Lesions in Neurodegenerative Dementia (2000) (72)
- End-of-life care and dementia (2005) (72)
- Don’t use antipsychotics routinely to treat agitation and aggression in people with dementia (2014) (72)
- Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home Survey. (2014) (71)
- Health and well‐being in care staff and their relations to organizational and psychosocial factors, care staff and resident factors in nursing homes (2009) (71)
- Coping by the carers of dementia sufferers. (1995) (70)
- Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies (2015) (70)
- ANXIETY DISORDERS IN DEMENTIA SUFFERERS (1996) (69)
- Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease (2015) (69)
- Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). (2009) (69)
- A follow up study of depression in the carers of dementia sufferers (1996) (69)
- A Detailed Phenomenological Comparison of Complex Visual Hallucinations in Dementia With Lewy Bodies and Alzheimer's Disease (1997) (68)
- The impact of rural land management changes on soil hydraulic properties and runoff processes: results from experimental plots in upland UK (2014) (68)
- Associations of Psychotic Symptoms in Dementia Sufferers (1995) (68)
- Contrast sensitivity and visual acuity in patients with Alzheimer's disease (2000) (68)
- Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease (2007) (67)
- Neuropsychiatric Symptoms in Mild Dementia with Lewy Bodies and Alzheimer’s Disease (2012) (67)
- The Prevalence of Autonomic Symptoms in Dementia and Their Association with Physical Activity, Activities of Daily Living and Quality of Life (2006) (67)
- Efficacy of pain treatment on mood syndrome in patients with dementia: a randomized clinical trial (2014) (67)
- Treatment of Behavioral and Psychological Symptoms of Alzheimer’s Disease (2012) (67)
- Update on Vascular Dementia (2016) (66)
- Associations between cognitively stimulating leisure activities, cognitive function and age‐related cognitive decline (2015) (66)
- Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. (2017) (65)
- Psychotic symptoms in patients with dementia (1995) (65)
- Postnatal depression in fathers (1996) (65)
- Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies (2007) (65)
- The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia (2010) (65)
- Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency (2016) (65)
- Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies (2002) (64)
- Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative (2017) (64)
- Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology. (2017) (64)
- Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types (2000) (63)
- High Prevalence of Orthostatic Hypotension in Mild Dementia (2009) (62)
- Diagnosing dementia with Lewy bodies (1999) (62)
- Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions (2004) (62)
- Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study. (2014) (62)
- Chronicity in postnatal depression (1994) (61)
- Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management (2013) (61)
- Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies (2003) (61)
- Drug repositioning and repurposing for Alzheimer disease (2020) (61)
- Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels (2009) (59)
- Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management (2020) (59)
- Course of neuropsychiatric symptoms in dementia: 5‐year longitudinal study (2018) (59)
- The characterisation and impact of ‘fluctuating’ cognition in dementia with Lewy bodies and Alzheimer's disease (2001) (59)
- Prevalence, symptom profile, and aetiology of depression in dementia sufferers. (1993) (59)
- A role for APP in Wnt signalling links synapse loss with β-amyloid production (2018) (58)
- Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study (2016) (58)
- Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI (2001) (58)
- Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies (2014) (57)
- Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. (1999) (56)
- EPIDEMIOLOGY OF PAIN IN PEOPLE WITH DEMENTIA LIVING IN CARE HOMES: LONGITUDINAL COURSE, PREVALENCE AND TREATMENT IMPLICATIONS (2017) (56)
- Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia (1999) (56)
- Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease (2001) (55)
- The prevalence of depression in the carers of dementia sufferers (1995) (55)
- Functional cognitive disorder: dementia's blind spot. (2020) (54)
- Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. (1996) (54)
- Long-Term Mortality in a Cohort of Home-Dwelling Elderly with Mild Alzheimer's Disease and Lewy Body Dementia (2014) (53)
- Absence of cholinergic deficits in “pure” vascular dementia (2005) (53)
- Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia (2012) (53)
- New and emerging treatments for Alzheimer's disease (2012) (53)
- Hyperintensities and Fronto-Subcortical Atrophy on MRI Are Substrates of Mild Cognitive Deficits after Stroke (2003) (53)
- Multidisciplinary research priorities for the COVID-19 pandemic – Authors' reply (2020) (53)
- Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study (2011) (53)
- Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease (2008) (52)
- Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial (2013) (52)
- Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study (2014) (52)
- Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies (2005) (52)
- Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies (2001) (50)
- Impact of antipsychotic review and non‐pharmacological intervention on health‐related quality of life in people with dementia living in care homes: WHELD—a factorial cluster randomised controlled trial (2017) (50)
- Autonomic Function Assessed by Heart Rate Variability Is Normal in Alzheimer’s Disease and Vascular Dementia (2005) (50)
- Synaptic proteins in CSF relate to Parkinson’s disease stage markers (2017) (50)
- Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial) (2016) (50)
- Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England (2009) (49)
- Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ‘Prevention of Decline in Cognition after Stroke Trial’ (PODCAST) Randomised Controlled Trial (2017) (49)
- The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study (2020) (49)
- DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT (2009) (49)
- COSMOS—improving the quality of life in nursing home patients: protocol for an effectiveness-implementation cluster randomized clinical hybrid trial (2015) (49)
- CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies (2010) (49)
- Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. (2015) (48)
- Mild Cognitive Impairment: the Manchester consensus (2020) (48)
- Survival time and differences between dementia with Lewy bodies and Alzheimer’s disease following diagnosis: A meta-analysis of longitudinal studies (2019) (48)
- A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice (2015) (48)
- Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study (1999) (48)
- Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications (2017) (47)
- Cardiovascular Effects of Donepezil in Patients with Dementia (2003) (47)
- Depression in the carers of dementia sufferers: a comparison of the carers of patients suffering from dementia with Lewy bodies and the carers of patients with Alzheimer's disease. (2000) (46)
- Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study. (2014) (46)
- CARERS' KNOWLEDGE OF DEMENTIA AND THEIR EXPRESSED CONCERNS (1997) (46)
- Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease (2013) (46)
- Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. (2001) (46)
- Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features (2011) (45)
- A Prospective Study of Psychotic Symptoms in Dementia Sufferers: Psychosis in Dementia (1997) (45)
- FITS into practice: translating research into practice in reducing the use of anti-psychotic medication for people with dementia living in care homes (2015) (45)
- The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS). (2019) (45)
- Pharmacological profile of an essential oil derived from Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels (2008) (45)
- Unfolded protein response is activated in Lewy body dementias (2016) (44)
- One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies (2000) (44)
- Early Discriminatory Diagnosis of Dementia with Lewy Bodies (2008) (44)
- Influence of the amyloid precursor protein locus on dementia in Down syndrome (2004) (44)
- Pimavanserin: Potential Treatment For Dementia-Related Psychosis (2018) (44)
- Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome (2013) (43)
- Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease (2008) (43)
- Lack of association of the α2-macroglobulin locus on chromosome 12 in AD (2000) (43)
- Utility, reliability, sensitivity and validity of an online test system designed to monitor changes in cognitive function in clinical trials (2017) (43)
- Drugs for Alzheimer's disease (2001) (42)
- Psychotic symptoms, aggression and restlessness in dementia. (1999) (42)
- Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. (2008) (42)
- Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome☆ (2014) (42)
- BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline (2009) (42)
- Butyrylcholinesterase: impact on symptoms and progression of cognitive impairment (2005) (41)
- Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology (2001) (41)
- Depression and synaptic zinc regulation in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia. (2015) (41)
- Mental health of people living with dementia in care homes during COVID-19 pandemic (2020) (41)
- Medial Temporal Lobe Width on CT Scanning in Alzheimer’s Disease: Comparison with Vascular Dementia, Depression and Dementia with Lewy Bodies (2000) (41)
- NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia (2004) (40)
- Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias (2006) (40)
- Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson’s Disease Dementia (2008) (40)
- The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. (2004) (40)
- Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism (2006) (40)
- Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible? (2010) (40)
- The role of pain treatment in managing the behavioural and psychological symptoms of dementia (BPSD). (2011) (40)
- Subtle Attentional Deficits in the Absence of Dementia Are Associated with an Increased Risk of Post-Operative Delirium (2007) (39)
- Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies (2001) (39)
- Vesicular glutamate transporter and cognition in stroke (2010) (39)
- Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design (2014) (39)
- Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults (2019) (39)
- Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease. (2007) (39)
- What is the prevalence of environmental hazards in the homes of dementia sufferers and are they associated with falls (2000) (39)
- Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex (2002) (38)
- Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study (2014) (37)
- Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life (2018) (37)
- (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study (2013) (37)
- Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. (2009) (36)
- The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study (2016) (36)
- Helping staff to implement psychosocial interventions in care homes: augmenting existing practices and meeting needs for support (2016) (36)
- Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta‐analyses (2018) (36)
- Implementing Remote Memory Clinics to Enhance Clinical Care During and After COVID-19 (2020) (36)
- Increased neural progenitors in vascular dementia (2011) (35)
- End of life treatment decisions in people with dementia: carers' views and the factors which influence them (2000) (35)
- Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia (2008) (34)
- Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neurons (2019) (34)
- Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. (1999) (34)
- Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial (2021) (34)
- Amyloid β concentrations in older people with Down syndrome and dementia (2009) (33)
- Choline Acetyltransferase Activity in Vascular Dementia and Stroke (2009) (33)
- Trial of Pimavanserin in Dementia-Related Psychosis. (2021) (33)
- Ethnic differences in adolescent self-poisoning: a comparison of Asian and Caucasian groups. (1991) (33)
- Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? (2005) (32)
- Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry (2016) (32)
- Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies (2006) (32)
- A failure of ‘Pop‐Out’ in visual search tasks in dementia with Lewy Bodies as compared to Alzheimer's and Parkinson's disease (2004) (32)
- Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans (2002) (32)
- Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease (2019) (32)
- Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. (2000) (32)
- Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease (2009) (31)
- A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. (2002) (31)
- Psychosis in Alzheimer disease — mechanisms, genetics and therapeutic opportunities (2022) (31)
- Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults (2020) (31)
- The Relationship between Post-Natal Depression, Somatization and Behaviour in Malaysian Women (2001) (31)
- Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems (2008) (31)
- New Therapeutic Strategies for Lewy Body Dementias (2017) (30)
- Online assessment of risk factors for dementia and cognitive function in healthy adults (2018) (30)
- Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research. (2019) (30)
- Postpartum anxiety in mothers and fathers (1993) (30)
- APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. (2004) (30)
- Associations of Awareness of Age-Related Change With Emotional and Physical Well-being: A Systematic Review and Meta-analysis (2019) (30)
- Longitudinal comparison of depression, coping, and turnover among NHS and private sector staff caring for people with dementia (2001) (30)
- Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets (2017) (30)
- Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. (2015) (29)
- Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. (2000) (29)
- Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment (2014) (29)
- Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies (2013) (29)
- Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM) (2018) (29)
- New and emerging treatments for Alzheimer’s disease (2012) (29)
- Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications (2018) (28)
- Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial (2016) (28)
- Familial Occurrence of Dementia and Parkinsonism (2006) (28)
- Psychiatric and behavioral symptoms in Alzheimer’s disease and other dementias: Etiology and management (2005) (28)
- Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03 (1999) (27)
- Quantifying the association between computerised measures of attention and confusion assessment method defined delirium: a prospective study of older orthopaedic surgical patients, free of dementia (2008) (27)
- Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial (2014) (27)
- Criteria for the diagnosis of dementia (2005) (27)
- Impact of Hypertension and Apolipoprotein E4 on Poststroke Cognition in Subjects >75 Years of Age (2005) (27)
- The aetiology of depression in the carers of dementia sufferers. (1995) (26)
- Dementia: Management of behavioural and psychological symptoms (2003) (26)
- Prescription of antipsychotics in people with dementia. (2014) (26)
- Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias (2016) (26)
- Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. (2007) (26)
- Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates (2011) (25)
- Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms (2018) (25)
- Intraoperative Optimization of Both Depth of Anesthesia and Cerebral Oxygenation in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery-A Randomized Controlled Pilot Trial. (2019) (25)
- Core and Suggestive Symptoms of Dementia with Lewy Bodies Cluster in Persons with Mild Dementia (2010) (25)
- Medial Temporal Lobe Atrophy and Depressive Symptoms in Elderly Patients With and Without Alzheimer Disease (2015) (25)
- A Prospective Study of Dementia with Lewy Bodies — Clinical Data (1998) (25)
- The K Variant of the Butyrylcholinesterase Gene Is Associated with Reduced Phosphorylation of Tau in Dementia Patients (2005) (24)
- For Debate: Should novel antipsychotics ever be used to treat the behavioral and psychological symptoms of dementia (BPSD)? (2005) (24)
- Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. (1999) (24)
- Efficacy of memantine in PDD and DLB: an extension study including washout and open‐label treatment (2011) (24)
- Correlation of Entorhinal Amyloid with Memory in Alzheimer’s and Vascular but Not Lewy Body Dementia (2005) (24)
- Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction (2020) (24)
- Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation. (2020) (24)
- Vascular cognitive impairment. (2001) (24)
- A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD). (2015) (24)
- The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease. (2019) (23)
- Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial (2013) (23)
- Anxiety disorder in dementia (1994) (23)
- Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies (2011) (23)
- Cognitive decline in a prospectively studied group of stroke survivors, with a particular emphasis on the >75's. (2002) (23)
- Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects? (2021) (23)
- Neuropsychological Deficits in Older Stroke Patients (2002) (23)
- Investigating the relationship between age of onset of depressive disorder and cognitive function (2018) (22)
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial (2021) (22)
- Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes. (2020) (22)
- Dementia with Lewy Bodies: Noncognitive symptoms in Lewy body dementia (1996) (22)
- Agitation and impulsivity in mid and late life as possible risk markers for incident dementia (2020) (22)
- Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias. (2014) (21)
- Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum. (2004) (21)
- NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors (2011) (21)
- Placement of dementia sufferers in residential and nursing home care. (1998) (21)
- The Extended Tau Haplotype and the Age of Onset of Dementia in Down Syndrome (2008) (21)
- Genetic Associations of Autopsy-Confirmed Vascular Dementia Subtypes (2011) (21)
- Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia (2014) (21)
- Antipsychotics and mortality in dementia. (2012) (21)
- Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes (2020) (21)
- Cognitive decline in Down syndrome. (2003) (20)
- Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer’s disease (1997) (20)
- Feasibility of a staff training and support programme to improve pain assessment and management in people with dementia living in care homes (2018) (20)
- Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease (2016) (20)
- Definition and Diagnosis of Dementia with Lewy Bodies (2003) (20)
- Dementia with Lewy Bodies (2001) (20)
- Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease (2011) (20)
- Treatment of Dementia with Lewy Bodies and Parkinson’s Disease Dementia (2011) (19)
- Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysis (2019) (19)
- The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs (2014) (19)
- Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis. (2020) (19)
- Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline (2007) (19)
- Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. (2000) (19)
- Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM) (2018) (19)
- Apathy and Its Response to Antipsychotic Review and Nonpharmacological Interventions in People With Dementia Living in Nursing Homes: WHELD, a Factorial Cluster Randomized Controlled Trial. (2016) (19)
- Person-centred care and care mapping in dementia (2009) (18)
- Subtle deficits of attention after surgery: quantifying indicators of sub syndrome delirium (2010) (18)
- What are the relations between Lewy body disease and AD? (1998) (18)
- APOE Genotype and Alzheimer´s Disease (2000) (18)
- Analgesic treatments in people with dementia - how safe are they? A systematic review (2019) (18)
- Agitation and psychosis in dementia. (2007) (18)
- Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer’s disease (2018) (18)
- The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer’s disease (2018) (18)
- PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial (2017) (17)
- Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT. (2020) (17)
- α-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies (2009) (17)
- A Pilot Study Examining Associations between DYRK1A and α-Synuclein Dementias (2012) (17)
- Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers (2022) (17)
- Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load. (2017) (17)
- Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease (2020) (17)
- VARIABLES WHICH DISTINGUISH PATIENTS FULFILLING CLINICAL CRITERIA FOR DEMENTIA WITH LEWY BODIES FROM THOSE WITH ALZHEIMER'S DISEASE (1997) (16)
- Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids (2013) (16)
- Subject Index Vol. 11, 2000 (2000) (16)
- International relevance of two measures of awareness of age-related change (AARC) (2020) (16)
- Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease (2019) (16)
- The cost of care homes for people with dementia in England: a modelling approach (2017) (16)
- Antipsychotic Drug Use Is Not Associated With Long-Term Mortality Risk in Norwegian Nursing Home Patients. (2016) (15)
- An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults (2019) (15)
- What influences the sustainability of an effective psychosocial intervention for people with dementia living in care homes? A 9 to 12‐month follow‐up of the perceptions of staff in care homes involved in the WHELD randomised controlled trail (2019) (15)
- Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias (2020) (15)
- Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia (2017) (15)
- Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease (2020) (15)
- Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer’s disease (2019) (15)
- Homocysteine and post-stroke cognitive decline. (2007) (15)
- Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs. (2007) (14)
- Antipsychotic efficacy and motor tolerability in a phase III placebo-controlled study of pimavanserin in patients with Parkinson's Disease psychosis (Acp-103-020) (2013) (14)
- Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study (2018) (14)
- Multiple substrates of late-onset dementia: implications for brain protection. (2001) (14)
- Psychiatric sequelae of MDMA (ecstasy) and related drugs (1994) (14)
- Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia (2018) (14)
- Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease (2002) (14)
- Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program (2018) (13)
- Continuity of GP care for patients with dementia: impact on prescribing and the health of patients (2022) (13)
- Impaired chronic pain‐like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease (2018) (13)
- Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease (vol 25, pg 559, 2008) (2008) (13)
- (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease. (2018) (13)
- Neuropsychiatric Symptoms and Functional Decline in Alzheimerʼs Disease and Lewy Body Dementia (2020) (13)
- Cross-sectional association between objective cognitive performance and perceived age-related gains and losses in cognition (2021) (13)
- Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs (2020) (12)
- Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study (2020) (12)
- LIVE@Home.Path—innovating the clinical pathway for home-dwelling people with dementia and their caregivers: study protocol for a mixed-method, stepped-wedge, randomized controlled trial (2020) (12)
- Analysis of Neuron-Specific Enolase and S100B as Biomarkers of Cognitive Decline Following Surgery in Older People (2012) (12)
- Mild Cognitive Impairment and Vascular Cognitive Impairment in Stroke Patients (2003) (12)
- Associations between ZnT3, tau pathology, agitation, and delusions in dementia (2018) (12)
- Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit (2007) (12)
- Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease. (2017) (12)
- Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5] (2014) (12)
- Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture (2012) (12)
- Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease (2020) (12)
- Online Education and Cognitive Behavior Therapy Improve Dementia Caregivers' Mental Health: A Randomized Trial. (2020) (11)
- Cognitive Impairment in Studies of 5HTTLPR and Psychosis in Alzheimer’s Disease: A Systematic Review (2013) (11)
- Loneliness, physical activity and mental health during Covid-19: a longitudinal analysis of depression and anxiety between 2015 and 2020. (2020) (11)
- Deliberate Self-poisoning in Asian and Caucasian 12–15–Year-Olds (1992) (11)
- Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients (2008) (11)
- Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling (2018) (11)
- Cerebrovascular Amyloidosis and Dementia (2003) (11)
- Emerging amyloid and tau targeting treatments for Alzheimer’s disease (2017) (11)
- Liraglutide and semaglutide: Pooled post hoc analysis to evaluate risk of dementia in patients with type 2 diabetes (2020) (11)
- Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti‐agitation properties: focus on ligand‐gated channels (2008) (11)
- Psychiatric features in diffuse Lewy body disease (1998) (11)
- Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease (2015) (10)
- Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies (2003) (10)
- The cross-sectional relationship between pain and awareness of age-related changes (2020) (10)
- An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome (2010) (10)
- Progressive brain atrophy on serial MRI in dementia with lewy bodies: A comparison with Alzheimer's disease and vascular dementia (2000) (10)
- Temporal Relationship Between Depressive Symptoms and Cognition in Mid and Late Life: A Longitudinal Cohort Study. (2020) (10)
- Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy (2019) (10)
- Alzheimer disease and stroke: Cognitive and neuroimaging predictors of AD and stroke (2013) (10)
- Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial (2019) (9)
- Anti-psychotic drug use in older people. (2002) (9)
- Effectiveness of collaborative care for elderly adults with Alzheimer's disease in primary care (2006) (9)
- Psychosis-associated DNA methylomic variation in Alzheimer's disease cortex (2020) (9)
- Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms? (2013) (9)
- White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid‐β precursor protein immunocytochemistry (2002) (9)
- School attendance as a factor in deliberate self poisoning by 12-15 year old adolescents. (1992) (9)
- Alzheimer's disease – a vascular dementia? (2003) (9)
- ( 123 I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study (2013) (9)
- CSF α-synuclein as a diagnostic biomarker for Parkinson disease and related dementias (2010) (9)
- FLAME: A computerized neuropsychological composite for trials in early dementia (2020) (9)
- Sleep problems and mental health difficulties in older adults who endorse high autistic traits (2020) (8)
- Sex differences in the association of mild behavioral impairment with cognitive aging (2021) (8)
- Cholinesterase inhibitors in the treatment of dementia (2003) (8)
- Thalamic D 2 receptors in dementia with Lewy bodies, Parkinson’s disease, and Parkinson’s disease dementia (2007) (8)
- The effectiveness of non-pharmacological interventions to prevent wandering in dementia (2006) (8)
- Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia (2019) (8)
- Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST) (2015) (8)
- Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial (2012) (8)
- Dynamin 1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia (2015) (8)
- Combining data mining and text mining for detection of early stage dementia:the SAMS framework (2016) (8)
- Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. (2004) (8)
- Evaluation of liraglutide in the treatment of Alzheimer's disease (2021) (8)
- Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial (2020) (8)
- Associations of subjective cognitive and memory decline with depression, anxiety, and two-year change in objectively-assessed global cognition and memory (2021) (8)
- Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients (2019) (7)
- A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol (2016) (7)
- Memantine improves attention and verbal episodic memory in Parkinson's disease dementia and dementia with Lewy bodies: A double-blind, placebo-controlled multicentre trial (2013) (7)
- DEPRESSION IN DEMENTIA SUFFERERS — COMPARISON OF DIAGNOSTIC CRITERIA (1997) (7)
- Factors influencing general practitioner referral to a child psychiatric service (1993) (7)
- The relationship between the frequency of number‐puzzle use and baseline cognitive function in a large online sample of adults aged 50 and over (2019) (7)
- Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depression (2011) (7)
- Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT (2020) (7)
- Novel pharmaceuticals in the treatment of psychosis in Parkinson’s disease (2014) (7)
- Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study) (2020) (7)
- Next-Generation RNA-Sequencing of Serum Small Extracellular Vesicles Discovers Potential Diagnostic Biomarkers for Dementia With Lewy Bodies. (2020) (7)
- A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol (2016) (7)
- Chronic Depersonalisation Neurosis au Shorvon – A Successful Intervention (1992) (7)
- The Mental and Physical Health of Older Adults With a Genetic Predisposition for Autism (2020) (7)
- Striatal Dopaminergic Deficit and Sleep in Idiopathic Rapid Eye Movement Behaviour Disorder: An Explorative Study (2021) (7)
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. (2021) (6)
- Alcohol and dementia: a complex relationship with potential for dementia prevention. (2018) (6)
- Dementia: challenges and promising developments (2011) (6)
- Patterns of Mitochondrial TSPO Binding in Cerebral Small Vessel Disease: An in vivo PET Study With Neuropathological Comparison (2020) (6)
- No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias (2012) (6)
- The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review – CORRIGENDUM (2014) (6)
- The impact of auditory hallucinations on “living well” with dementia: Findings from the IDEAL programme (2021) (6)
- Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease. (2014) (6)
- Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis (2020) (6)
- Depression and psychotic symptoms in dementia sufferers (1995) (6)
- Psychiatric issues in non-Alzheimer dementias (2004) (6)
- Eating disorder in a 6-year-old Asian girl with ethyl malonic adipic aciduria. (1993) (6)
- Different forms of psychological interventions in dementia (2004) (6)
- Relationship between self-perceptions of aging and 'living well' among people with mild-to-moderate dementia: Findings from the ideal programme. (2021) (6)
- Antipsychotics in patients with Alzheimer's disease—what is their clinical value? (2007) (6)
- Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease. (2019) (6)
- The mental and physical health profiles of older adults who endorse elevated autistic traits. (2020) (6)
- Whole transcriptome in silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side effects (2020) (6)
- Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force (2021) (6)
- Exploring awareness of age-related changes among over 50s in the UK: findings from the PROTECT study (2021) (6)
- Transcription-based drug repurposing for COVID-19 (2020) (5)
- Alzheimer's Disease Progression in the 5×FAD Mouse Captured with a Multiplex Gene Expression Array. (2019) (5)
- Is apolipoprotein e4 associated with cognitive decline in depression? (2001) (5)
- Author Correction: Parkinson disease-associated cognitive impairment (2021) (5)
- Sensory stimluation in dementia (2002) (5)
- Does the falls efficacy scale international version measure fear of falling: a reassessment of internal validity using a factor analytic approach (2014) (5)
- Study of the use of anti-depressants for depression in dementia : the HTA-SADD Trial-a multicentre randomised double-blind , placebo-controlled trial of the clinical effectiveness of sertraline and mirtazapine (2011) (5)
- Prevalence of abnormal eating amongst elderly people in residential care (2000) (5)
- Melissa aromatherapy as safe and effective treatment (2003) (5)
- Impact of person-centered care training and person-centered activities on quality of life, agitation and antipsychotic use in people with dementia living in nursing homes: a cluster-randomized controlled trial of the WHELD intervention. PLoS Medicine, 15 (2). (2017) (5)
- Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia. (2015) (5)
- Traumatic life experiences and post‐traumatic stress symptoms in middle‐aged and older adults with and without autistic traits (2021) (4)
- Audit of new long-stay patients in a district general hospital (1994) (4)
- Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial (2020) (4)
- In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer’s disease (2021) (4)
- Psychiatric and neuropsychiatric syndromes and COVID-19 (2020) (4)
- Stage-Speci fi c Changes in Neurogenic and Glial Markers in Alzheimer ’ s Disease (2015) (4)
- Historical landmarks in dementia with Lewy bodies (2017) (4)
- Lower cognitive baseline scores predict cognitive training success after 6 months in healthy older adults: Results of an online RCT (2020) (4)
- Dementia Care MappingTM to reduce agitation in care home residents with dementia : The DCM™ EPIC cluster randomised controlled trial (2019) (4)
- [abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease (2003) (4)
- Association between schizophrenia polygenic score and psychotic symptoms in Alzheimer’s disease: meta-analysis of 11 cohort studies (2019) (4)
- Erratum to “Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome” [Neurobiol. Aging 35 (2014) 1513.e1–1513.e5] (2014) (4)
- Discomfort in dementia: identifying and managing pain (2012) (4)
- Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias (2021) (4)
- NHS Continuing Care (2010) (4)
- The pre-dementia stage of dementia with Lewy bodies (2011) (4)
- The Charles Bonnet Syndrome associated with vascular pathology – a classical presentation with a very atypical course (1991) (4)
- Clinical management of dementia (2004) (4)
- Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies. (2021) (4)
- Cholinesterase Inhibitors in Parkinson’s Disease (2010) (4)
- Depth of anaesthesia optimisation and postoperative cognitive dysfunction. (2015) (4)
- UNINTENDED EFFECTS OF Z-DRUGS (ZOLPIDEM, ZOPICLONE AND ZALEPLON) IN PEOPLE LIVING WITH DEMENTIA (2018) (4)
- The phenomena of “bingeing” (1992) (3)
- Controlled Clinical Trials Reports on Alzheimer's Disease (2000) (3)
- Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias (2013) (3)
- Current perspectives in dementia with Lewy bodies (2006) (3)
- Predictors of changes after reasoning training in healthy adults (2020) (3)
- Dementia: New guidelines on disorders associated with dementia (2012) (3)
- Seasonal variation in the prevalence of postnatal depression (1993) (3)
- Dynamin protein in stroke and vascular dementia (2014) (3)
- Pharmacological management of neuropsychiatric symptoms in people with dementia (2009) (3)
- Antidepressants and mortality risk in a dementia cohort – data from SveDem, the Swedish Dementia Registry (2016) (3)
- Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease. (2018) (3)
- Spectrum of Lewy body dementias: relationship of Parkinson’s disease dementia to dementia with Lewy bodies (2010) (3)
- Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s disease (2019) (3)
- Healthy adjustment for new residents with dementia using SettleIN: A feasibility study in UK care homes (2018) (3)
- Atypical antipsychotics fail to improve functioning or quality of life in people with Alzheimer’s disease (2009) (3)
- Drugs used to relieve behavioural symptoms of dementia (2004) (3)
- Reducing psychotropic drug use in people with dementia living in nursing homes (2020) (3)
- What does feeling younger or older than one’s chronological age mean to men and women? Qualitative and quantitative findings from the PROTECT study (2021) (3)
- Carbamazepine in alcohol withdrawal (1991) (3)
- Differences in awareness of positive and negative age-related changes accounting for variability in health outcomes (2021) (3)
- Muscarinic M1 Receptor Coupling to G-protein is Intact in Parkinson's Disease Dementia. (2016) (3)
- RESULTS OF A PRAGMATIC, CLUSTER RANDOMISED, CONTROLLED TRIAL OF THE EFFECTIVENESS AND COST-EFFECTIVENESS OF DEMENTIA CARE MAPPING (DCM) IN UK CARE HOMES (DCM EPIC TRIAL) (2018) (3)
- MAGD Trial-Memantine for Agitation in Alzheimer's Dementia (2011) (3)
- BEYOND ANTIPSYCHOTICS: EXPLORING EFFICACY AND HARMS OF Z-DRUGS FOR SLEEP DISTURBANCE ON THE PROGRESSION OF KEY DEMENTIA OUTCOMES (2018) (3)
- Cognitive stimulation therapy: training, maintenance and implementation in clinical trials (2014) (3)
- AN EVALUATION OF PREDICTORS AND COGNITIVE DECLINE ASSOCIATED WITH PERSISTENT AND TRANSIENT PSYCHOTIC SYMPTOMS IN ALZHEIMER’S DISEASE (2017) (3)
- Risky drinking and cognitive impairment in community residents aged 50 and over (2021) (3)
- Patient involvement in clinical trials (2022) (3)
- Medication compliance and dispensing among psychogeriatric patients (1991) (2)
- RPT6, 20S α-6 AND α-3 PROTEASOME SUBUNIT LEVELS AND ASSOCIATION WITH COGNITIVE DECLINE IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS (2017) (2)
- Christmas census at a district general hospital psychiatric unit (1991) (2)
- PROFILE OF MILD BEHAVIOURAL IMPAIRMENT IN A POPULATION-BASED SAMPLE OF ADULTS AGED 50 AND OVER: INITIAL FINDINGS FROM THE PROTECT STUDY (2018) (2)
- Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts (2021) (2)
- Attention and fluctuating attention in dementia with Lewy bodies and Alzheimer's disease (2001) (2)
- Potential beneficial effects of masupirdine (SUVN‐502) on agitation/aggression and psychosis in patients with moderate Alzheimer's disease: Exploratory post hoc analyses (2022) (2)
- Autonomic dysfunction is present in dementia with Lewy bodies. (2005) (2)
- Persistent depressive symptoms are associated with frontal regional atrophy in patients with Alzheimer's disease (2022) (2)
- A genetically immortalized human stem cell line: a promising new tool for Alzheimer's disease therapy (2015) (2)
- Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial (2022) (2)
- CLINICAL TRIAL PIPELINES FOR ALZHEIMER’S DISEASE POSE CHALLENGES FOR FUTURE EFFECTIVE TREATMENT AND THERAPIES (2018) (2)
- Improving diagnosis of possible DLB (2013) (2)
- Decreased burden among caregivers of patients with Parkinson’s disease psychosis (PDP) treated with pimavanserin, a selective 5-HT2A inverse agonist (P6.044) (2015) (2)
- Vulnerability, coping and crisis (1991) (2)
- BIOMARKERS FOR COGNITIVE DECLINE OF EARLY PARKINSON’S DISEASE (2014) (2)
- Successful therapeutic intervention in a schizophrenic patient with blepharospasm. (1989) (2)
- Barriers to evidence-based prescribing in Alzheimer's disease (2013) (2)
- When the drugs don't work - or do they? (2005) (2)
- Stem-cells: Prospects for treating dementia (2008) (2)
- Healthcare utilisation and physical activities for older adults with comorbidities in the UK during COVID-19. (2021) (2)
- Butyrylcholinesterase: Potential Importance for the Symptoms and Progression of Cognitive Decline in People with Dementia (2003) (2)
- Health Differences Among People With Varying Profiles of Awareness of Positive and Negative Age-Related Changes (2020) (2)
- Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies (2013) (2)
- Dispersed Sleep Microstates and Associated Structural Changes in GBA1 Mouse: Relevance to Rapid Eye Movement Behavior Disorder (2021) (2)
- Screening for dementia: an opportunity for debate (2011) (2)
- Efficacy of galantamine in probable vascular dementia: an effective option for managing behavioural problems (2002) (2)
- A RANDOMIZED CONTROLLED TRIAL EVALUATING THE IMPACT OF AN E-LEARNING INTERVENTION BASED ON THE IMPROVING WELL-BEING AND HEALTH FOR PEOPLE WITH DEMENTIA (WHELD) PERSON-CENTRED CARE TRAINING PROGRAMME (2018) (2)
- Behavioral alternatives to anti-psychotic prescribing for people with dementia in residential care settings (2012) (2)
- Is there a case for ‘unidisciplinary working’ in child psychiatry? (1992) (2)
- Contents Vol. 15, 2003 (2003) (2)
- ONLINE COGNITIVE TRAINING INCREASES NEUROGENESIS AND IMPROVES COGNITIVE PERFORMANCE IN ADULTS OVER 50 (2017) (2)
- Preventing dementia (2005) (2)
- Are subtypes of affective symptoms differentially associated with change in cognition over time: A latent class analysis. (2022) (2)
- head direction cells in the anterodorsal thalamus Active and passive movement are encoded equally by (2012) (2)
- Information provision services in dementia care. (2011) (2)
- Biomarkers for dementia diagnosis: differentiating DLB and FTD may be difficult (2012) (2)
- Impact of psychosis on quality of life and well‐being in dementia (2020) (1)
- A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia. (2022) (1)
- Erratum to: Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management (2014) (1)
- Neurochemistry of Severe Dementia (2005) (1)
- Serial MR image registration and analysis techniques applied to studies of differential cerebral atrophy in late-onset dementia. (2000) (1)
- Defeating dementia: Current approaches to potential amyloid-based Alzheimer's disease therapies (2008) (1)
- Video decision support affects patients’ care choices in dementia care planning (2010) (1)
- Identification of Nonverbal Communication Tools for Use in Dementia (2021) (1)
- A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinued (2012) (1)
- Novel CSF biomarkers for frontotemporal lobar degeneration with lesions immunoreactive to TDP-43 (FTLD-TDP) (1)
- Higher perceived age‐related gains and losses relate to lower objective cognitive scores (2020) (1)
- Linking electronic dementia care records to national inpatient data in dementia with Lewy bodies: Frequency, duration and cost implications of hospitalization and recording of delirium episodes (2020) (1)
- REPEATED COGNITIVE TESTING REDUCES SAMPLE SIZE NECESSARY TO DETECT CLINICALLY RELEVANT EFFECTS (2018) (1)
- APP INTRON 7 POLYMORPHISM AND PLASMA AMYLOID-BETA PEPTIDE LEVELS CAN PREDICT THE ONSET OF DEMENTIA IN DOWN’S SYNDROME (2014) (1)
- Impairments in attention and fluctuating attention distinguish between dementia with lewy bodies and Alzheimer's disease (2000) (1)
- Subject Index Vol. 14, 2002 (2002) (1)
- Prevalence and profile of cognitive impairment and dementia in patients with carotid sinus syndrome (CSS) and carotid sinus hypersensitivity (CSH) (2005) (1)
- Can Brain Training Games Improve Cognition in Peope Over 60? (2010) (1)
- S3-04-04 Dementia with Lewy bodies: update definition and clinical studies (2004) (1)
- Fast Facts: Psychosis in Parkinson's Disease (2019) (1)
- DEMENTIA HOSPITAL CARE RESEARCH PROGRAMME: PERI-OPERATIVE ENHANCED RECOVERY HIP FRACTURE CARE OF PATIENTS WITH DEMENTIA (PERFECTED)—CLUSTER RANDOMISED CONTROL TRIAL RESULTS (2019) (1)
- Cross-Sectional and Longitudinal Associations between Subjective Sleep Difficulties and Self-Perceptions of Aging (2021) (1)
- Cholinergic pathology in Lewy body dementia (2006) (1)
- A randomized double blind clinical trial comparing memantine and antipsychotics for the prophylaxis of behavioural and psychological symptoms in people with Alzheimer's disease (MAIN AD) (2012) (1)
- Aromatherapy in dementia Clive Holmes & Clive Ballard (2004) (1)
- Eating Disorders in Alzheimer's Disease (2002) (1)
- Computerized neuropsychological tests undertaken on digital platforms are cost effective, achieve high engagement, distinguish and are highly sensitive to longitudinal change: Data from the PROTECT and GBIT studies (2020) (1)
- Investigating the effects of impairment in non‐verbal communication on neuropsychiatric symptoms and quality of life of people living with dementia (2021) (1)
- Antipsychotic efficacy and good tolerability in a Phase III placebo-controlled study of pimavanserin in patients with Parkinson's disease psychosis (ACP-103-020) (2013) (1)
- Psychotic Episodes in Alzheimer’s Disease (2017) (1)
- Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis. (2021) (1)
- mavanserin for patients with Parkinson ’ s disease psychosis : a randomised , placebo-controlled phase 3 trial (2013) (1)
- 122 Use of Pimavanserin in Patients With Parkinson’s Disease Psychosis: Subgroup Analysis of Efficacy and Safety in Patients With and Without Cognitive Impairment (2018) (1)
- Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011–2022 Update (2022) (1)
- D2 receptors in thalamus and cortex in Parkinson's disease dementia (PDD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB) (2006) (1)
- Neuropsychiatric Co-Morbidity in Dementia With and Without Movement Disorders (2003) (1)
- Cholinesterase inhibitors and the heart in old age (2004) (1)
- Correction: Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial (2013) (1)
- [abstract] A Randomized controlled trial of aromatherapy for dementia (2003) (1)
- Evidence-based prevention and treatment of dementia – Authors' reply (2016) (1)
- Latent subtypes of manic and/or irritable episode symptoms in two population-based cohorts – ERRATUM (2022) (1)
- Psychological interventions for neuropsychiatric symptoms in dementia (2012) (1)
- A NEURONAL CONNECTIVITY MAP (NMAP) DATABASE TO ESTABLISH A DRUG-SCREENING PLATFORM FOR AD (2019) (1)
- Progression of Cognitive Impairments Associated With Cerebrovascular Disease (2005) (1)
- Safety and Efficacy of Memantine Extended-Release in the Management of Alzheimer’s Disease (2013) (1)
- Postoperative cognitive decline, dementia and anaesthesia. (2007) (1)
- Agitation and nursing home structure- how are they related?: A three country study (2009) (1)
- The cognitive profile of middle‐aged and older adults with high vs. low autistic traits (2022) (1)
- Butyrylcholinesterase: Impact on symptoms and progression of cognitive impairment in dementia (2004) (1)
- Management of behavioural and psychological symptoms of dementia: Development of a best practice guide (2012) (1)
- P1-435 Essential oils as potential treatment for agitation in severe dementia: Elucidation of the pharmacological mechanism of Melissa and Lavender oils (2006) (1)
- PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trial (2022) (1)
- Cost-Effectiveness of an Online Intervention for Caregivers of People Living With Dementia. (2022) (1)
- Development and assessment of a brief screening tool for psychosis in dementia (2021) (1)
- Predictors of activities of daily living in heathy older adults: Who benefits most from online cognitive training? (2021) (1)
- A Randomized Controlled Trial of a Digital Adaptation of the WHELD Person-Centered Nursing Home Training Program. (2022) (1)
- Lifetime Traumatic Brain Injury and Cognitive Domain Deficits in Late Life: The PROTECT-TBI Cohort Study. (2023) (1)
- Skeleton services (1990) (1)
- P01-371 - Shorter Time Until Nursing Home Admission in Lewy Body Dementias as Compared to Alzheimer's Dementia (2010) (1)
- Reply: Functional cognitive disorder: dementia's blind spot. (2021) (1)
- RISK AND DURATION OF HOSPITALIZATION IN DEMENTIA WITH LEWY BODIES (2017) (1)
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis (2022) (1)
- Prevention of Alzheimer's disease (2005) (1)
- Relevance of sleep and associated structural changes in GBA1 mouse to human rapid eye movement behavior disorder (2022) (1)
- Child psychiatry liaison services (1991) (1)
- Neuroanatomical substrates in Parkinson’s Disease psychosis and their association with serotonergic receptor gene expression: A coordinate-based meta-regression analysis (2022) (1)
- GENOME-WIDE ASSOCIATION OF ALZHEIMER’S DISEASE WITH DYSPHORIA AND EVALUATION OF GENETIC OVERLAP WITH MAJOR DEPRESSIVE DISORDER (2019) (1)
- Trajectories of cognitive change following stroke: stepwise decline towards dementia in the elderly (2022) (1)
- Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease (2022) (1)
- RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus (2022) (1)
- A data‐driven examination of apathy and depressive symptoms in dementia with independent replication (2022) (1)
- Contents Vol. 25, 2008 (2008) (0)
- DEPRESSION IS ASSOCIATED WITH IMPAIRMENT IN COGNITIVE FUNCTION IN ADULTS AGED 50 AND OVER (2018) (0)
- Treatment of Psychosis in Parkinson's disease and Parkinson's disease dementia (2014) (0)
- IMPACT OF WHELD INTERVENTION ON NEUROPSYCHIATRIC SYMPTOMS, ANTIPSYCHOTIC USE AND QUALITY OF LIFE IN PEOPLE WITH DEMENTIA LIVING IN NURSING HOMES: A CLUSTER-RANDOMIZED TRIAL (2017) (0)
- PAIN AND AGITATION IN DEMENTIA Authors' reply to McShane and Regnard (2011) (0)
- A DYRK1A polymorphism and dementia (2010) (0)
- Casebook: assessing confusion. (2002) (0)
- Randomized controlled trial of mibampator for behavioral and psychological symptoms of dementia: comments on the trial and thoughts for future studies – ADDENDUM (2014) (0)
- THE COURSE OF APATHY IN PEOPLE WITH DEMENTIA (2019) (0)
- NONVERBAL COMMUNICATION AND QUALITY OF LIFE OF PEOPLE WITH DEMENTIA (2016) (0)
- Drs. Ballard and McKeith Reply (2000) (0)
- C.10.02 Management of behavioural problems in Alzheimer's disease (2007) (0)
- OPTIMISING FALLS RISK ASSESSMENT IN MEMORY SERVICES: INVESTIGATING SYSTEM-WIDE INTEGRATION OF FALL PREVENTION EVIDENCE INTO PRACTICE (2017) (0)
- Influence of cerebral glucose metabolic rate on cognitive function in Alzheimer's subjects (2020) (0)
- IDALOPIRDINE, A 5-HT6 ANTAGONIST, AS ADJUNCTIVE THERAPY TO ACETYLCHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-MODERATE ALZHEIMER’S DISEASE: KEY OUTCOMES FROM THE STAR PHASE III PROGRAM (2017) (0)
- THE ASSOCIATION BETWEEN COGNITIVE FUNCTION AND ACTIVITIES OF DAILY LIVING IN HEALTHY ADULTS AGED 50 AND OVER (2017) (0)
- Outcome Measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: systematic review and consensus (2017) (0)
- Impact of current antipsychotic medications on comparative mortality and adverse events in people with Parkinson’s disease psychosis (PDP) (2016) (0)
- Impairment of the proteasome on frontal cortex in lewy body dementia (2011) (0)
- Post-operative cognitive decline, dementia and anaesthesia (2007) (0)
- For peer review only ( 123 I)FP -CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study (2013) (0)
- Authors’ reply to McShane and Regnard (2011) (0)
- Pharmacological management of behavioral and psychological symptoms in dementia (2011) (0)
- P1-563 REPORT FROM BELGRADE DEMENTIA CENTER: A STEP TOWARD IMPROVING THE QUALITY OF DIAGNOSTICS AND TREATMENT OF DEMENTIA PATIENTS IN CLINICAL PRACTICE (2017) (0)
- Dementia with Lewy Bodies and Parkinson's Disease Dementia Editors: JOHN O'BRIEN, IAN MCKEITH, DAVID AMES AND EDMOND CHIU, London, Taylor and Francis, 2005, £75.00 Hard cover, pp. 264 ISBN 1 8418 4491 8 (2006) (0)
- NO IMPROVEMENT IN NURSING HOME CARE FOR PEOPLE WITH DEMENTIA SINCE THE MILLENNIUM (2019) (0)
- A GENETICALLY IMMORTALIZED HUMAN STEM CELL LINE: A PROMISING NEW TOOL FOR ALZHEIMER’S DISEASE THERAPY (2016) (0)
- Better together for better dementia research and care. (2016) (0)
- CAN INCREASING THE DIFFICULTY OF A NEUROGENESIS-SENSITIVE TASK ENHANCE ITS SENSITIVITY TO DETECTING AGE-RELATED DECLINES IN VOLUNTEERS AGED 50 TO 96? (2017) (0)
- Role of Neuropsychiatric Assessment in Diagnosis and Research (2005) (0)
- Efficacy and safety of pimavanserin in patients with Alzheimer’s dementia psychosis in the HARMONY phase 3, randomized discontinuation study: a post hoc subgroup analysis (2022) (0)
- Microglial Phenotype and in vivo Labelling in Cerebral Small Vessel Disease: an [11C]PBR28 PET Study (2019) (0)
- Assessing the relationship between cognitive dysfunction and brain atrophy in Alzheimer's disease (2020) (0)
- Supplementary material (Baek et al. 2015) (2015) (0)
- P3-087: Neuropsychiatric correlates of CSF Tau and P-Tau in dementia (2008) (0)
- Neuropsychiatric symptoms and cognitive decline: Trait or state effects? (2020) (0)
- DOES INSULIN RESISTANCE INFLUENCE WHITE MATTER LESIONS IN NON-DIABETIC AD SUBJECTS? (2019) (0)
- A consensus guideline for antipsychotic drug use for dementia in long-term care; collecting expert opinion through Delphi-consensus and focus groups (2013) (0)
- Contents Vol. 23, 2007 (2007) (0)
- FAMILY HISTORY OF DEMENTIA WITH PSYCHOTIC SYMPTOMS IN THE COGNITIVELY NORMAL POPULATION: FEASIBILITY OF MEASUREMENT AND INITIAL CLINICAL AND GENETIC ASSOCIATIONS (2019) (0)
- USE OF HEARING AIDS IN OLDER ADULTS WITH HEARING LOSS IS ASSOCIATED WITH IMPROVED COGNITIVE TRAJECTORY (2019) (0)
- Cerebral atrophy in dementia with Lewy bodies studied using voxel-based morphometry (2002) (0)
- Influence of the Tau Haplotype on Progression and Treatment Response of Neuropsychiatric Symptoms in People With Alzheimer's Disease (P2.153) (2014) (0)
- A Preliminary Investigation of the Views of People With Parkinson's (With and Without Psychosis) and Caregivers on Participating in Clinical Trials During the Covid-19 Pandemic: An Online Survey (2020) (0)
- Management of Agitation, Aggression, and Psychosis Associated With Alzheimer’s Disease (2014) (0)
- IS1.07: A consensus guideline for antipsychotic drug use for dementia in long-term care. Collecting expert opinion through Delphi-consensus and focus groups (2014) (0)
- THE RESPONSE OF AGITATED BEHAVIOR TO PAIN MANAGEMENT IN PERSONS WITH DEMENTIA. RCT TRIAL (2017) (0)
- Synaptic proteins in CSF relate to Parkinson’s disease stage markers (2017) (0)
- UK Validation of Two Measures of Awareness of Age-Related Change (AARC) (2019) (0)
- A Role for Epigenetic Mechanisms in the Lewy Body Dementias (2022) (0)
- COGNITIVE TRAJECTORIES OF HEALTHY OLDER ADULTS OVER THREE YEARS: A LARGE-SCALE LONGITUDINAL ANALYSIS (2019) (0)
- COVID‐19 and vaccination programme in one residential home (2021) (0)
- Management of agitation and aggression: controversies and possible solutions (2012) (0)
- International Journal of Geriatric Psychiatry the Characterisation and Impact Of`¯uctuating' Cognition in Dementia with Lewy Bodies and Alzheimer's Disease (0)
- P2-225: The frequency of dementia with Lewy bodies in a community-based referral sample of mild dementia (2008) (0)
- 38. LATENT SUBTYPES OF MANIC OR IRRITABLE EPISODE SYMPTOMS IN TWO POPULATION-BASED COHORTS (2021) (0)
- PERIPHERAL INSULIN RESISTANCE DOES NOT CORRELATE WITH CEREBRAL GLUCOSE METABOLIC RATE IN NON-DIABETIC ALZHEIMER’S PATIENTS (2018) (0)
- In‐silico high throughput whole transcriptome screening implicates cardiovascular disease and the immune system in the mechanism of action underlying adverse effects of atypical antipsychotics (2020) (0)
- Tracing Carbon in Karst Environments in South-Central Kentucky to Identify Changes in Groundwater Dynamic Under Varying Land Uses (2016) (0)
- Cholinergic and Serotonergic Systems in Severe Dementia (2006) (0)
- GENETIC OVERLAP BETWEEN PSYCHOTIC SYMPTOMS ACROSS THE LIFESPAN: FINDINGS FROM SCHIZOPHRENIA, COGNITIVELY NORMAL OLDER ADULTS AND ALZHEIMER’S DISEASE (2018) (0)
- Randomized controlled trial of memantine for agitation in dementia (2011) (0)
- META-ANALYSIS OF AARC AND EMOTIONAL AND PHYSICAL WELL-BEING (2019) (0)
- Corrigendum (2013) (0)
- REPRINTED WITH PERMISSION OF IASP – PAIN 162 (2021) 999–1006: Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease (2021) (0)
- P1-523 THERELATIONSHIPBETWEENTHEMILD BEHAVIOURAL IMPAIRMENT CHECKLIST (MBI-C) TOTAL SCORE AND CORE ASPECTS OF COGNITIVE FUNCTION IN OLDER ADULTS (2018) (0)
- Cognitive & Behavioral Neurology, Memory Disorders, and Frontotemporal Disorders Units/Divisions, and MA Alzheimer's Disease Research Center Attending Staff, Harvard Partners Neurology Departments Geriatric Research, Education and Clinical Center Attending Staff, New England GRECC and ENRM Veterans (2014) (0)
- Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ’Prevention of Decline in Cognition after Stroke Trial’ (POD- (2018) (0)
- A SUMMARY OF THE RATIONALE AND DESIGN OF THE HARMONY STUDY: A PHASE 3 STUDY TO EVALUATE PIMAVANSERIN FOR THE TREATMENT OF HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH DEMENTIA-RELATED PSYCHOSIS (2018) (0)
- IMPAIRED CHRONIC PAIN-LIKE BEHAVIOUR AND DISRUPTION OF OPIOIDERGIC SYSTEM IN TASTPM MODEL OF ALZHEIMER’S DISEASE (2018) (0)
- Relationship between spectral analysis, SUV and SUV Pons ratio as a measure of cerebral glucose metabolic rate in Alzheimer's disease (2020) (0)
- The association between depression and cognitive impairment in type 2 diabetes (2018) (0)
- The role of serotonin and the effects of acute dietary depletion of tryptophan on cognitive and non-cognitive symptoms in Alzheimer's disease (1999) (0)
- INTENSIVE SHORT-TERM ONLINE COGNITIVE TRAINING IN GRAMMATICAL REASONING CONFERS BENEFITS TO COGNITION AND FUNCTION IN OLDER ADULTS: OUTCOMES FROM THE START RANDOMISED CONTROLLED TRIAL (2019) (0)
- Clinical relevance of butyrylcholinesterase in the human subcortex (2008) (0)
- Importance of proactive treatment of depression in Lewy body dementias: The impact on hippocampal neurogenesis and cognition in a postmortem study. Short title Impact of SSRIs on neurogenesis, depression and cognition in DLB/PDD (2019) (0)
- Symposia (2009) (0)
- Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches (2015) (0)
- Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia (2008) (0)
- Heart rate variability is reduced in dementia with Lewy bodies but not Alzheimer’s disease or vascular dementia. (2003) (0)
- On the role of common pathological features in Alzheimers disease and vascular dementia (2000) (0)
- INFORMANT- AND PARTICIPANT-REPORTED COGNITIVE FUNCTION USING THE IQCODE MEASURE IS A ROBUST INDICATOR OF COGNITIVE HEALTH (2019) (0)
- Erratum to: Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture (2013) (0)
- No association of COMT vanl 158met polymorphism and psychotic symptoms in Lewy body dementias (vol 531, pg 1, 2014) (2014) (0)
- Subject Index Vol. 25, 2008 (2008) (0)
- The Impact of Genetics Associated with Age of Onset of Alzheimer’s Disease in People with Down’s Syndrome Upon Beta-Amyloid and Tau Concentrations (2011) (0)
- Effectiveness and acceptability of non-pharmacological methods to reduce wandering in people with dementia: incorporating users' perspectives into systematic reviews (2005) (0)
- A MULTIPLEX BIOMARKER ASSAY FOR MEASURING TRANSCRIPTIONAL CHANGES IN THE 5XFAD MOUSE MODEL OF AD (2019) (0)
- PIMAVANSERIN IN ALZHEIMER’S DISEASE PSYCHOSIS: SUBGROUP ANALYSIS OF THE MORE SEVERE POPULATION (2018) (0)
- A POST HOC ANALYSIS OF STUDY ACP-103-019 EVALUATING THE IMPACT OF A REDUCTION IN PSYCHOSIS ON THE SEVERITY OF AGITATION AND AGGRESSION IN PATIENTS WITH ALZHEIMER'S DISEASE (2019) (0)
- Impaired chronic pain-like behaviour and disruption of the opioidergic system in Alzheimer's disease (2018) (0)
- 4 Optimal treatment for parkinson patients with cognitive disorders (2012) (0)
- Assessment scales in the management of Alzheimer’s disease (2009) (0)
- Different forms of psychological (2004) (0)
- EVALUATING SHARED GENETIC LIABILITY FOR LATE-LIFE ABNORMAL THOUGHTS AND PERCEPTION (MILD BEHAVIORAL IMPAIRMENT), AND NEUROLOGICAL AND PSYCHIATRIC CONDITIONS (2019) (0)
- Development and assessment of a brief screening tool for psychosis in dementia (2021) (0)
- [abstract] White matter hyperintensities are associated with impairment of memory and attention in older stroke patients (2003) (0)
- CHARACTERISING THE COGNITIVE PROFILE ASSOCIATED WITH INDIVIDUAL DOMAINS OF MID BEHAVIOURAL IMPAIRMENT IN THE COGNITIVELY NORMAL POPULATION (2019) (0)
- Corrigendum to “Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies” [Neurosci. Lett. 557 (2013) 177–180] (2014) (0)
- Prevention of Decline in Cognition after Stroke Trial: Final results of a factorial randomised trial of blood pressure and lipid lowering (PODCAST) (2014) (0)
- The impact of the COVID‐19 pandemic on cognitive health (2021) (0)
- dementia with Lewy bodies: a longitudinal case study (2013) (0)
- Neurodegenerative disease associated pathways in brain of the triple transgenic Alzheimer’s model are reversed in vivo following two weeks peripheral administration of fasudil (2022) (0)
- HARMONY: Response to pimavanserin in the 12‐week, open‐label treatment phase (2020) (0)
- Contents Vol. 11, 2000 (2000) (0)
- [abstract] Neuroimaging changes in vascular mild cognitive impairment (MCI) (2003) (0)
- Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis. (2021) (0)
- A data‐driven examination of clustering of apathy and depression symptoms in people with dementia (2021) (0)
- Pandemic impact in care homes: Care homes perspectives (2021) (0)
- Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program (2018) (0)
- Investigating neuroinflammation in small vessel disease with [11C]PBR28 PET imaging and post-mortem tissue validation (2019) (0)
- Self-harm and Suicidality Experiences of Middle-Age and Older Adults With vs. Without High Autistic Traits. (2022) (0)
- LifelineN Turan trained in neurology and vascular (2012) (0)
- Antipsychotic prescriptions and neuropsychiatric symptoms (NPS) in nursing home (NH)residents with dementia: a comparison of pre‐ and during COVID pandemic. (2022) (0)
- INVOLVEMENT OF ELEVATED NEUROINFLAMMATION IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER’S DISEASE (2018) (0)
- Efficacy of memantine in PDD and DLB: An extension study including wash-out and open-label treatment (2010) (0)
- Levels of Loneliness and Mental Health in Older Adults across Ethnic Groups During the COVID-19 Pandemic in the UK (2023) (0)
- dementia: randomised controlled trial Cost-effectiveness analyses for mirtazapine and sertraline in (2013) (0)
- Proceedings of the Annual Meeting of the British Neuropsychiatry Association, the Institute of Child Health, central London, 15–16 February 2001 (2001) (0)
- THE RELATIONSHIP BETWEEN SELF-REPORTED MONTHLY PHYSICAL EXERCISE FREQUENCY AND COGNITIVE FUNCTION (2017) (0)
- Understanding primary care diagnosis and management of sleep disturbance for people with dementia or mild cognitive impairment: a realist review protocol (2022) (0)
- Commentary re: "TIME - Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms" in the context of Emerging Evidence regarding Training Interventions for dementia in Nursing Homes (2017) (0)
- Front & Back Matter (2020) (0)
- Diagnostic Criteria for Functional Psychosis (2nd edn). By P. Berner, E. Gabriel, H. Katschnig, W. Kieffer, K. Koehler, G. Lenz, D. Nutzinger, H. Schanda and C. Simbandl Cambridge: Cambridge University Press. 1992. 268 pp. £45.00. (1993) (0)
- AN ONLINE ASSESSMENT OF THE INFLUENCE OF VASCULAR RISK FACTORS ON COGNITIVE FUNCTION IN HEALTHY ADULTS AGED 50 AND ABOVE (2019) (0)
- Depression and anxiety are associated with decline in executive function over two years in adults 50 and over (2020) (0)
- ASSOCIATION OF SELF-REPORTED PHYSICAL EXERCISE FREQUENCY AND COGNITIVE TRAJECTORY IN OLDER ADULTS (2019) (0)
- Relationship between genetic risk for Alzheimer's, cognition and neuropsychiatric symptoms: A case study of DNA sampling and analysis through digital platform cohort studies (2020) (0)
- An Epigenome‐wide association study of psychosis in Alzheimer's disease dorsolateral prefrontal cortex (2022) (0)
- Evaluating the effects of the novel GLP-1 analogue liraglutide in patients with Alzheimer's disease (ELAD Study) (2019) (0)
- The following abstracts were presented at the Annual Spring Meeting of the Association of Cardiothoracic Anaesthetists (ACTA) in Cambridge, June 2013 (2013) (0)
- A special thanks to our reviewers for 2013. (2014) (0)
- Characterization of Depressive Symptoms in Dementia and Examination of Possible Risk Factors (2023) (0)
- Homocysteine and post-stroke cognition (2005) (0)
- Diagnosing Dementia-Related Psychosis: Using Tools and Communicating With Patients and Caregivers. (2020) (0)
- A TRIAGE SYSTEM FOR IDENTIFYING CANDIDATE COMPOUNDS FOR REPURPOSING AS POTENTIAL THERAPEUTICS FOR AD (GATT) (2018) (0)
- Subject Index Vol. 23, 2007 (2007) (0)
- G-protein coupling to muscarinic M1 receptors is differentially affected in neurodenegerative dementias (2012) (0)
- Synaptic dysfunction and correlations with clinico-pathological features in dementia with Lewy bodies and Parkinson's disease dementia (2013) (0)
- ABC of Monitoring Drug Therapy. By J. K. Aronson, M. Hardman and D. J. M. Reynolds London: BMJ. 1993. 38 pp. £6.95. (1994) (0)
- IDENTIFYING ENRICHMENT FACTORS THAT PREDICT ALZHEIMER’S DISEASE PROGRESSION: AN ANALYSIS OF THREE RANDOMIZED, CONTROLLED TRIALS (2018) (0)
- The clinical use of memantine. (2005) (0)
- Non-Alzheimer Dementias (2000) (0)
- COGNITIVE FUNCTION AND ACTIVITIES OF DAILY LIVING IN HEALTHYADULTS (2017) (0)
- People with dementia and carers experience a broad range of benefits from anticholinesterase drug treatments (2014) (0)
- P2-226: Association of proteasome subunit expression with reduced proteolytic activity in dementia with Lewy bodies and Parkinson's disease dementia (2008) (0)
- Rumination moderates the longitudinal associations of awareness of age-related change with depressive and anxiety symptoms. (2023) (0)
- P4-064: Neuroleptic medication is associated with selective alterations in VCSF Aβ40 and tau in patients with intractable unipolar depression (2008) (0)
- PODCAST Trial Investigators; (2017) Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot ’Prevention of Decline in Cognition (2019) (0)
- Repeated concussions associated with worsened working memory, attention and processing speed, but preserved delayed memory: A PROTECT study (2021) (0)
- Impact of brisk walking on cognitive decline in adults with and without early impairment: A FLAME analysis in the PROTECT cohort (2021) (0)
- A RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO INVESTIGATE SAFETY OF BUPRENORPHINE TRANSDERMAL SYSTEM FOR PAIN MANAGEMENT IN PEOPLE WITH DEMENTIA (2018) (0)
- Additional primary care patient characteristics (2021) (0)
- Healthcare utilisation, physical activity and mental health during COVID-19 lockdown: an interrupted time-series analysis of older adults in England (2022) (0)
- ENGAGING STUDENTS IN KARST GEOLOGY IN THE MAMMOTH CAVE REGION THROUGH THE WESTERN KENTUCKY UNIVERSITY KARST FIELD STUDIES PROGRAM (2018) (0)
- Can Intraoperative Optimization of Both Anesthetic Depth and Cerebral Oxygenation Really Result in Different Influences on Cognitive Function and Delirium in Elderly Patients Undergoing Cardiac Surgery? Response to Letter to the Editor by Xue et al. (2020) (0)
- Healthcare utilisation, physical activity and mental health during COVID-19 lockdown: an interrupted time-series analysis of older adults in England. (2022) (0)
- Characterisation of white matter pathology in vascular dementia and Alzheimer's disease (2002) (0)
- Neurotoxicity of general anaesthesia is hypothetical Reply from the (0)
- Impact of Psychotic Symptoms and Concurrent Neuropsychiatric Symptoms on the Quality of Life of People With Dementia Living in Nursing Homes. (2022) (0)
- Parallel randomized controlled feasibility trials of the “Active Brains” digital intervention to protect cognitive health in adults aged 60–85 (2022) (0)
- Differences in awareness of positive and negative age-related changes accounting for variability in health outcomes. (2022) (0)
- The association of the of late‐life onset psychotic symptoms with incident cognitive impairment in a cognitively normal sample. (2022) (0)
- Impact of the Covid‐19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings (2023) (0)
- Polymorphisms in BACE 2 may affect the age of onset Alzheimer ’ s dementia in Down syndrome q (0)
- Attitudes toward own aging and cognition among individuals living with and without dementia: findings from the IDEAL programme and the PROTECT study (2021) (0)
- Neural substrates in Parkinson's Disease psychosis: A systematic review (2022) (0)
- Antipsychotics: No quick fix for people with dementia (2008) (0)
- Self and informant‐rated mild behavioral impairment and genetic risk for AD: The respondent matters (2021) (0)
- Higher Awareness of Positive and Negative Age-Related Changes Relate to Lower Objective Cognitive Scores (2020) (0)
- GENOME WIDE ASSOCIATION STUDY: IDENTIFYING GENETIC MARKERS IN APATHY IN PEOPLE WITH ALZHEIMER’S DISEASE (2019) (0)
- Opportunities for Combination Trials (2019) (0)
- iWHELD, A Novel Digital Non‐Pharmacological Intervention with Live Virtual Coaching Reduces Antipsychotic Use in Nursing Home Residents with Dementia Compared to Usual Care in a 16‐week RCT (2022) (0)
- Fluctuations in attention: PD dementia vs DLB with parkinsonism (2002) (0)
- HEALTH ECONOMIC ANALYSIS OF THE IMPROVING WELL-BEING AND HEALTH FOR PEOPLE WITH DEMENTIA (WHELD) PERSON-CENTRED CARE TRAINING FOR THE TREATMENT OF AGITATION IN PEOPLE WITH DEMENTIA: A CLUSTER RANDOMIZED CONTROLLED TRIAL (2018) (0)
- OP45 Continuity of general practitioner care for patients with dementia: impact on prescribing and the health of patients (2022) (0)
- The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence (2022) (0)
- The impact of low dementia research funding on brain health for decision makers: A reflection on current health statistics (2023) (0)
- Behavioural symptoms in Alzheimer’s disease are associated with white matter lesions (WML) volume and are independent of atrophy and hypometabolism (2020) (0)
- Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease (2022) (0)
- Grey matter volume loss in Parkinson’s disease psychosis and its relationship with serotonergic gene expression: A meta-analysis (2023) (0)
- Pimavanserin and dementia-related psychosis (2022) (0)
- UPDATE Functional cognitive disorder: dementia’s blind spot (2020) (0)
- Contents Vol. 14, 2002 (2002) (0)
- RELATIONSHIP BETWEEN PATHOLOGY SCORES, CLINICAL DATA AND EXPRESSION LEVELS OF PROTEASOME SUB-UNITS IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS (2017) (0)
- PW01-89 - Symtoms Of Dementia With Lewy Bodies Cluster In Persons With Mild Dementia (2010) (0)
- Hypertension, brain training and cognition in the healthy adults aged over 50 years: An online longitudinal study (2021) (0)
- Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias (2016) (0)
- Characterisation of D409V/WT mice as a novel dementia model (2022) (0)
- SPECT in suspected dementia with Lewy bodies : a longitudinal case study (2013) (0)
- Management of Noncognitive Symptoms in Dementia with Lewy Bodies (1998) (0)
- CHARACTERIZING CARBON TRANSPORT AND DISSOLUTION PROCESSES IN A COMPLEX KARST GROUNDWATER REVERSAL SYSTEM AT MAMMOTH CAVE, KENTUCKY, USA (2016) (0)
- Optimizing psychosocial interventions for people with dementia living in care homes (2011) (0)
- Prevalence, incidence and prediction of falls in dementia and Parkinson’s disease: a prospective study in the elderly (2007) (0)
- CLINICO-PATHOLOGIC CORRELATIONS IN DEMENTIA WITH LEWY BODIES (DLB): A PROSPECTIVE COHORT STUDY (2016) (0)
- Title: Temporal relationship between depressive symptoms and cognition in mid and late life: A longitudinal cohort study Author names and affiliations (2020) (0)
- P2-214: Blood pressure reaction to orthostatic challenge is different in dementia with Lewy bodies (2008) (0)
- Benign intracranial hypertension and repeated self-mutilation (1989) (0)
- Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects? (2021) (0)
- INSULIN RESISTANCE INFLUENCES HIPPOCAMPAL GLUCOSE METABOLISM RATHER THAN HIPPOCAMPAL VOLUME IN NON-DIABETIC ALZHEIMER’S DISEASE PATIENTS (2019) (0)
- Ansorge, Ulrich, 528 Arnel Trevena, Judy, 162, 308 (2002) (0)
- The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence (2022) (0)
- Cholinergic and Monoaminergic Correlates of Clinical Symptoms in Dementia with Lewy Bodies (2002) (0)
- The course of depressive symptoms in Lewy body dementia and Alzheimer's disease. (2023) (0)
- EMERGING FROM BETWEEN A ROCK AND A HARD PLACE: TREATING THE NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA (2011) (0)
- P4-017 CLINICAL TRIAL PIPELINES FOR ALZHEIMER’S DISEASE POSE CHALLENGES FOR FUTURE EFFECTIVE TREATMENTAND THERAPIES IMPAIRED CHRONIC PAIN-LIKE BEHAVIOUR AND DISRUPTION OF OPIOIDERGIC SYSTEM IN TASTPM MODEL OF ALZHEIMER’S DISEASE (0)
- S5-04-03: Alternative therapies for behavioral problems (2008) (0)
- Stroke, genetic risk and incidence of dementia (2020) (0)
- Genetic risk, education and incidence of dementia (2020) (0)
- THE RELATIONSHIP OF SYNAPTIC PROTEINS WITH AGE IN DOWN SYNDROME (2017) (0)
- Reply to Reporting Changes in Scores on the Cohen-Mansfield Agitation Inventory Subscales (2003) (0)
- University of Groningen A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice Zuidema, (2015) (0)
- Using the SARS Infection Transcriptional Signature to Identify Potential Treatments for Covid-19 (2020) (0)
- Original article: A GENETICALLY IMMORTALIZED HUMAN STEM CELL LINE: A PROMISING NEW TOOL FOR ALZHEIMER'S DISEASE THERAPY (2015) (0)
- 2. Bradyarrhythmias, Sick Sinus Syndrome & Carotid Sinus Syndrome (2005) (0)
- A role for epigenetic mechanisms in Lewy body dementias (2021) (0)
- Letter to the editor (1990) (0)
- Erratum: Patient and carer views on participating in clinical trials for prodromal Alzheimer's disease and mild cognitive impairment (2014) (0)
- Long-Term Antipsychotics Increase Mortality Risk in AD Patients The Dementia Antipsychotic Withdrawal Trial ( DART-AD ) : Long-Term Follow-Up of a Randomised Placebo-Controlled Trial (2010) (0)
- Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias (2022) (0)
- Corrigendum to “No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias” [Neurosci. Lett. 531 (1) (2012) 1–4] (2014) (0)
- IN THE WAKE OF THE ANTIPSYCHOTIC BLACK BOX WARNINGS: WHERE DO WE GO FROM HERE WITH BEHAVIORAL DISTURBANCES IN DEMENTIA? (2010) (0)
- Sexual abuse: Crisis and response to counselling (1991) (0)
- Visual hallucinations in neurological disease: pathophysiology and management (2020) (0)
- Tc-99m HMPAO SPECT image analysis in dementia with Lewy bodies and Alzheimer's disease using statistical paramentric mapping (2002) (0)
- Time to discontinuation similar for atypical antipsychotic drugs and placebo in people with Alzheimer’s disease (2007) (0)
- Cognitive Impairment and the Dementias (2014) (0)
- Contents Vol. 19, 2005 (2005) (0)
- A CORE OUTCOME SET FOR DISEASE MODIFICATION TRIALS IN MILD-TO-MODERATE DEMENTIA: A SYSTEMATIC REVIEW AND CONSENSUS RECOMMENDATIONS (2017) (0)
- Rivastigmine for the Treatment of Parkinson’s Disease Dementia (2010) (0)
- PREVALENCE AND CO-MORBIDITY OF APATHY AND DEPRESSION IN ALZHEIMER’S DISEASE (2017) (0)
- Delusional disorder in tropical spastic paraparesis (1994) (0)
- IN A POPULATION-BASED OF ADULTS AGED 50 AND OVER: INITIAL FINDINGS FROM THE PROTECT STUDY (2018) (0)
- Acute mood and cognitive effects of a novel herbal extract (ONP-22) in healthy elderly volunteers (2002) (0)
- CHRONIC PAIN IS ASSOCIATED WITH POOR COGNITIVE TRAJECTORY IN OLDER ADULTS (2019) (0)
- EFFICACY, COST-EFFECTIVENESS AND SUSTAINED ENGAGEMENT OF THE IMPROVING WELL-BEING AND HEALTH FOR PEOPLE WITH DEMENTIA (WHELD) PERSON-CENTERED CARE TRAINING PROGRAMME (2018) (0)
- PSYCHOSIS-ASSOCIATED EPIGENETIC VARIATION IN PATIENTS WITH ALZHEIMER’S DISEASE ACROSS CORTICAL BRAIN REGIONS (2018) (0)
- TIME in the Context of Emerging Evidence Regarding Training Interventions for Dementia in Nursing Homes. (2018) (0)
- Pharmacological Treatment of Alzheimer's Disease (2008) (0)
- Subject Index Vol. 19, 2005 (2005) (0)
- PERI-OPERATIVE ENHANCED RECOVERY HIP FRACTURE CARE OF PATIENTS WITH DEMENTIA (PERFECTED): RCT RESULTS (2019) (0)
- Psychotic Symptoms in Dementia (2005) (0)
- Clinical experience with polygenic risk score in subjects with early cognitive concerns (2021) (0)
- THE RELATIONSHIP BETWEEN THE FREQUENCY OF WORD PUZZLE USE AND COGNITIVE FUNCTION IN A LARGE SAMPLE OF ADULTS AGED 50 TO 96 YEARS (2017) (0)
- HALLUCINATIONS AND DELUSIONS ASSOCIATEDWITH DEMENTIA-RELATED PSYCHOSIS (2018) (0)
- Contribution of Alzheimer's disease and Lewy body pathology to behavior and cognition in Lewy body dementias (2013) (0)
- ' s response to reviews Title : Baseline characteristics , statistical analysis plan and report on feasibility for the ' Prevention Of Decline in Cognition After Stroke Trial ' ( PODCAST ) trial (2015) (0)
- Examination of cognitive performance and mild behavioral impairment domains of apathy, mood, impulse dyscontrol, social inappropriateness and psychosis in cognitively normal adults aged 50 and over (2021) (0)
- Memantine for agitation in dementia (2011) (0)
- RISK FACTORS FOR DEMENTIA AND COGNITIVE FUNCTION IN HEALTHY ADULTS (2017) (0)
- THE RELATIONSHIP BETWEEN THE MILD BEHAVIOURAL IMPAIRMENT CHECKLIST (MBI-C) TOTAL SCORE AND CORE ASPECTS OF COGNITIVE FUNCTION IN OLDER ADULTS (2018) (0)
- Subject Index Vol. 15, 2003 (2003) (0)
- Parkinson/Dementia complex and Lewy body dementia: perspectives and treatments (2008) (0)
- WHELD: AN RCT OF AN OPTIMIZED NON-PHARMACOLOGICAL INTERVENTION TO IMPROVE AGITATION AND QUALITY OF LIFE IN 1006 PEOPLE WITH DEMENTIA LIVING IN NURSING HOMES (2016) (0)
- The pattern of cognitive performance in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (2004) (0)
- Cholinesterase inhibitors may exacerbate hypotensive episodes related to neurocardiovascular instability in people with dementia (2000) (0)
This paper list is powered by the following services:
Other Resources About Clive Ballard
What Schools Are Affiliated With Clive Ballard?
Clive Ballard is affiliated with the following schools:
